# Intuitive Surgical Inc. (ISRG)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $149.44B  
**Price:** $412.02 (-3.42%)

> Intuitive Surgical, Inc. is a medical technology company that develops, manufactures, and markets robotic-assisted systems designed to support minimally invasive care in hospitals and healthcare facilities worldwide. Its primary platforms include the da Vinci Surgical System, which enables surgeons to perform complex procedures through small incisions with enhanced precision, visualization, and control, and the Ion endoluminal system, which focuses on minimally invasive lung biopsies and diagnostic procedures. Intuitive Surgical provides a comprehensive ecosystem around these systems, including surgical instruments, disposable accessories, vision and imaging technologies, training, and technical support services. The company works closely with surgeons and healthcare providers across specialties such as urology, gynecology, general surgery, and thoracic care, aiming to broaden access to minimally invasive treatment options. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $10.06B | $6.64B | $2.95B | $2.86B | $7.87 |
| 2024 | $8.35B | $5.63B | $2.35B | $2.32B | $6.42 |
| 2023 | $7.12B | $4.73B | $1.77B | $1.80B | $5.03 |
| 2022 | $6.22B | $4.20B | $1.58B | $1.32B | $3.65 |
| 2021 | $5.71B | $3.96B | $1.82B | $1.70B | $4.66 |
| 2020 | $4.36B | $2.86B | $1.05B | $1.06B | $2.94 |
| 2019 | $4.48B | $3.11B | $1.37B | $1.38B | $3.85 |
| 2018 | $3.72B | $2.60B | $1.20B | $1.13B | $9.49 |
| 2017 | $3.14B | $2.20B | $1.06B | $671M | $5.77 |
| 2016 | $2.71B | $1.89B | $950M | $738M | $6.26 |
| 2015 | $2.38B | $1.58B | $740M | $589M | $5.18 |
| 2014 | $2.13B | $1.41B | $545M | $419M | $11.11 |
| 2013 | $2.27B | $1.59B | $853M | $671M | $16.73 |
| 2012 | $2.18B | $1.57B | $878M | $657M | $15.98 |
| 2011 | $1.76B | $1.27B | $695M | $495M | $12.32 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $20.46B | $2.52B | $17.82B | $3.37B | — |
| 2024 | $18.74B | $2.21B | $16.43B | $2.03B | — |
| 2023 | $15.44B | $2.04B | $13.31B | $2.75B | — |
| 2022 | $12.97B | $1.86B | $11.04B | $1.58B | — |
| 2021 | $13.55B | $1.60B | $11.90B | $1.29B | — |
| 2020 | $11.17B | $1.41B | $9.73B | $1.62B | — |
| 2019 | $9.73B | $1.45B | $8.26B | $1.17B | — |
| 2018 | $7.85B | $1.16B | $6.68B | $858M | — |
| 2017 | $5.78B | $996M | $4.78B | $648M | — |
| 2016 | $6.49B | $709M | $5.78B | $1.04B | — |
| 2015 | $4.91B | $588M | $4.32B | $715M | — |
| 2014 | $3.96B | $580M | $3.38B | $600M | — |
| 2013 | $3.95B | $449M | $3.50B | $782M | — |
| 2012 | $4.06B | $479M | $3.58B | $554M | — |
| 2011 | $3.06B | $418M | $2.65B | $466M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $3.03B | — | — |
| 2024 | $2.42B | — | — |
| 2023 | $1.81B | — | — |
| 2022 | $1.49B | — | — |
| 2021 | $2.09B | — | — |
| 2020 | $1.48B | — | — |
| 2019 | $1.60B | — | — |
| 2018 | $1.17B | — | — |
| 2017 | $1.14B | — | — |
| 2016 | $1.09B | — | — |
| 2015 | $806M | — | — |
| 2014 | $665M | — | — |
| 2013 | $880M | — | — |
| 2012 | $814M | — | — |
| 2011 | $678M | — | — |

Source: [CompaniesByCap](https://companiesbycap.com/company/ISRG)